The goal of this project is to study the molecular mechanism by which transforming growth factor-beta (TGF-Beta) induces cell death. TGF-Beta has been shown to be a potent growth-inhibitory factor for cells derived from lymphoid and hematopoietic origins. To investigate and elucidate the molecular mechanism of TGF-Beta signaling pathway that leads to programmed cell death, this proposal seeks to study whether several key players of the TGF-Beta growth inhibitory pathway are involved in TGF-Beta induced apoptosis in leukemic and other cancer cells. Efforts will also be made to identify other unknown molecules which mediate this specific TGF-Beta effect.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA068770-01
Application #
2112799
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1996-01-05
Project End
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705